Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease

  • McCrory D
  • Brown C
80Citations
Citations of this article
87Readers
Mendeley users who have this article in their library.

You may have access to this PDF.

Abstract

Inhaled bronchodilators form the mainstay of treatment for acute exacerbations of COPD. Two types of agent are used routinely, either singly or in combination: anticholinergic agents and beta2-sympathomimetic agonists.

Cite

CITATION STYLE

APA

McCrory, D. C., & Brown, C. D. (2003). Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd003900

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free